Advertisement

Intracranial Self-Stimulation

  • Styliani Vlachou
  • Athina Markou
Protocol
Part of the Neuromethods book series (NM, volume 53)

Abstract

Intracranial self-stimulation (ICSS) is an operant behavioral paradigm in which experimental animals learn to deliver brief electrical pulses into specific regions of their own brains that are considered to be part of the brain’s reward pathways mediating both natural and ICSS reward. Several brain sites support ICSS, with the lateral hypothalamus, medial forebrain (MFB) bundle, and ventral tegmental area (VTA) among the sites that produce the most vigorous ICSS responding. Various ICSS procedures have been designed and used during the last decades since the discovery of ICSS. Two of the most commonly used ICSS procedures, which have been experimentally validated and have shown to be reward-selective, are the rate-frequency curve-shift procedure and the discrete-trial current-intensity threshold procedure. In all ICSS procedures, lowering of ICSS thresholds indicates a facilitation of brain stimulation reward, whereas elevations in ICSS thresholds reflect the diminished reward value of the stimulation and thus an anhedonic state. Acute administration of most drugs of abuse, including cocaine, amphetamine, nicotine, morphine, and heroin, lower ICSS thresholds in experimental animals. By contrast, withdrawal from chronic administration of these compounds induces elevations in ICSS thresholds, indicating an anhedonic state that resembles the negative affective state of the drug withdrawal syndrome experienced by humans. However, certain drugs of abuse, such as ethanol and cannabinoids, have shown inconsistent effects in ICSS procedures, primarily because of the minimal effects induced by these drugs in the ICSS procedure. In summary, the ICSS procedure provides unique ways to investigate the anatomical basis of reward and motivation and is an important tool for the assessment of the reward-facilitating and anhe­donic effects of various drugs of abuse with addictive properties.

Key words

Intracranial self-stimulation Reward Motivation Drugs of abuse Cocaine Amphetamine Nicotine Heroin Morphine Δ9-Tetrahydrocannabinol Ethanol Benzodiazepines Phencyclidine Reward-facilitating effect Anhedonia Drug dependence Depression 

Notes

Acknowledgments

This work was supported by National Institutes of Health research grants U01 MH69062 from the National Institute of Mental Health and R01 DA11946 and R01 DA232090 from the National Institute on Drug Abuse to AM. Dr. Styliani Vlachou was supported by individual Postdoctoral Research Fellowship 18FT-0048 from the Tobacco-Related Disease Research Program from the State of California. The authors wish to thank Janet Hightower for outstanding graphics.

References

  1. 1.
    Rolls ET (1975) The neural basis of brain-stimulation reward. Prog Neurobiol 3:73–160PubMedGoogle Scholar
  2. 2.
    Hall RD, Bloom FE, Olds J (1977) Neuronal and neurochemical substrates of reinforcement. Neurosci Res Program Bull 15:131–314PubMedGoogle Scholar
  3. 3.
    Esposito RU, Motola AHD, Kornetsky C (1978) Cocaine: acute effects on reinforcement thresholds for self-stimulation behavior to the medial forebrain bundle. Pharmacol Biochem Behav 8:437–439PubMedGoogle Scholar
  4. 4.
    Wise RA, Bozarth MA (1981) Brain substrates for reinforcement and drug self-administration. Prog Neuropsychopharmacol 5:467–474PubMedGoogle Scholar
  5. 5.
    Stellar JR, Stellar E (1990) The ­neurobiology of reward and motivation. Springer-Verlag, New YorkGoogle Scholar
  6. 6.
    Olds J, Milner P (1954) Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 47:419–427PubMedGoogle Scholar
  7. 7.
    Yeomans JS (1990) “Temporal summation decay” in hypothalamic self-stimulation: threshold changes at long intrapair intervals due to axonal subnormal periods. Behav Neurosci 104:991–999PubMedGoogle Scholar
  8. 8.
    Markou A, Koob GF (1993) Intracranial self-stimulation thresholds as a measure of reward. In: Sahgal A (ed) Behavioral neuroscience: a practical approach, vol 2. IRL Press, Oxford, pp 93–115Google Scholar
  9. 9.
    Miliaressis E, Rompre PP, Durivage A (1982) Psychophysical method for mapping behavioral substrates using a moveable electrode. Brain Res Bull 8:693–701PubMedGoogle Scholar
  10. 10.
    Gallistel CR, Shizgal P, Yeomans JS (1981) A portrait of the substrate for self-stimulation. Psychol Rev 88:228–273PubMedGoogle Scholar
  11. 11.
    Markou A, Koob GF (1992) Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav 51:111–119PubMedGoogle Scholar
  12. 12.
    Frank RA, Markou A, Wiggins LL (1987) A systematic evaluation of the properties of self-stimulation train-duration response functions. Behav Neurosci 101:546–559PubMedGoogle Scholar
  13. 13.
    Markou A, Frank RA (1987) The effect of operant and electrode placement on self-stimulation train duration response ­functions. Physiol Behav 41:303–308PubMedGoogle Scholar
  14. 14.
    Wise RA (1996) Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19:319–340PubMedGoogle Scholar
  15. 15.
    Edmonds DE, Gallistel CR (1974) Parametric analysis of brain stimulation reward in the rat: III. Effect of performance variables on the reward summation function. J Comp Physiol Psychol 87:876–883PubMedGoogle Scholar
  16. 16.
    Franklin KB (1978) Catecholamines and self-stimulation: reward and performances effects dissociated. Pharmacol Biochem Behav 9:813–820PubMedGoogle Scholar
  17. 17.
    Campbell KA, Evans G, Gallistel CR (1985) A microcomputer-based method for physiologically interpretable measurement of the rewarding efficacy of brain stimulation. Physiol Behav 35:395–403PubMedGoogle Scholar
  18. 18.
    Miliaressis E, Rompre PP, Laviolette P, Philippe L, Coulombe D (1986) The curve-shift paradigm in self-stimulation. Physiol Behav 37:85–91PubMedGoogle Scholar
  19. 19.
    Kornetsky C, Esposito RU (1979) Euphorigenic drugs: effects on the reward pathways of the brain. Fed Proc 38:2473–2476PubMedGoogle Scholar
  20. 20.
    Kornetsky C, Esposito RU, McLean S, Jacobson JO (1979) Intracranial self-stimulation thresholds: a model for the hedonic effects of drugs of abuse. Arch Gen Psychiatry 36:289–292PubMedGoogle Scholar
  21. 21.
    Stein L, Ray OS (1960) Brain stimulation reward “thresholds” self-determined in rat. Psychopharmacologia 1:251–256PubMedGoogle Scholar
  22. 22.
    Schaefer GJ, Holtzman SG (1979) Free-operant and auto-titration brain self-stimulation procedures in the rat: a comparison of drug effects. Pharmacol Biochem Behav 10:127–135PubMedGoogle Scholar
  23. 23.
    Zarevics P, Setler PE (1981) Effects of GABAergic drugs on brain stimulation reward as assessed by a “threshold” method. Brain Res 215:201–209PubMedGoogle Scholar
  24. 24.
    Neill D, Gaar L, Clark A, Britt M (1982) “Rate-free” measures of self-stimulation and microinjections: evidence toward a new ­concept of dopamine and reward. In: Hoebel BG, Novin D (eds) The neural basis of feeding and reward. Haer Institute for Electrophysiological Research, Brunswick, ME, pp 289–298Google Scholar
  25. 25.
    Fouriezos G, Wise RA (1976) Pimozide-induced extinction of intracranial self-­stimulation: response patterns rule out motor or performance deficits. Brain Res 103:377–380PubMedGoogle Scholar
  26. 26.
    Franklin KB, McCoy SN (1979) Pimozide-induced extinction in rats: stimulus control of responding rules out motor deficit. Pharmacol Biochem Behav 11:71–75PubMedGoogle Scholar
  27. 27.
    Fenton HM, Liebman JM (1982) Self-stimulation response decrement patterns ­differentiate clonidine, baclofen and do­ppamine antagonists from drugs causing performance deficit. Pharmacol Biochem Behav 17:1207–1212PubMedGoogle Scholar
  28. 28.
    Gallistel CR, Boytim M, Gomita Y, Klebanoff L (1982) Does pimozide block the reinforcing effect of brain stimulation? Pharmacol Biochem Behav 17:769–781PubMedGoogle Scholar
  29. 29.
    Huston JP, Mills AW (1971) Threshold of reinforcing brain stimulation. Commun Behav Biol 5:331–340PubMedGoogle Scholar
  30. 30.
    Cassens GP, Mills AW (1973) Lithium and amphetamine: opposite effects on threshold of intracranial reinforcement. Psychophar­macologia 30:283–290PubMedGoogle Scholar
  31. 31.
    Herrnstein RJ (1974) Formal properties of the matching law. J Exp Anal Behav 21:159–164PubMedGoogle Scholar
  32. 32.
    Hamilton AL, Stellar JR, Hart EB (1985) Reward, performance, and the response strength method in self-stimulating rats: validation and neuroleptics. Physiol Behav 35:897–904PubMedGoogle Scholar
  33. 33.
    Liebman JM, Gerhardt S, Prowse J (1982) Differential effects of d-amphetamine, ­pipradrol and bupropion on shuttlebox self-stimulation. Pharmacol Biochem Behav 16:791–794PubMedGoogle Scholar
  34. 34.
    Liebman JM, Hall N, Prowse J (1982) Effects of various catecholamine receptor antagonists, muscle relaxation and physical hindrance on shuttlebox self-stimulation. Pharmacol Biochem Behav 16:785–790PubMedGoogle Scholar
  35. 35.
    Greenshaw AJ, Sanger DJ, Blackman DE (1985) Effects of d-amphetamine and of β-phenylethylamine on fixed interval responding maintained by self-regulated lateral hypothalamic stimulation in rats. Pharmacol Biochem Behav 23:519–523PubMedGoogle Scholar
  36. 36.
    Valenstein ES (1964) Problems of measurement and interpretation with reinforcing brain stimulation. Psychol Rev 71:415–437PubMedGoogle Scholar
  37. 37.
    Liebman JM (1983) Discriminating between reward and performance: a critical review of intracranial self-stimulation methodology. Neurosci Biobehav Rev 7:45–72PubMedGoogle Scholar
  38. 38.
    Coulombe D, Miliaressis E (1987) Fitting intracranial self-stimulation data with growth models. Behav Neurosci 101:209–214PubMedGoogle Scholar
  39. 39.
    Carlezon WA Jr, Chartoff EH (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987–2995PubMedGoogle Scholar
  40. 40.
    Miliaressis E, Rompre PP (1987) Effects of concomitant motor reactions on the measurement of rewarding efficacy of brain stimulation. Behav Neurosci 101:827–831PubMedGoogle Scholar
  41. 41.
    Gallistel CR, Freyd G (1987) Quantitative determination of the effects of catecholaminergic agonists and antagonists on the rewarding efficacy of brain stimulation. Pharmacol Biochem Behav 26:731–741PubMedGoogle Scholar
  42. 42.
    Stellar JR, Rice MB (1989) Pharmacological basis of intracranial self-stimulation reward. In: Liebman JM, Cooper SJ (eds) The ­neuropharmacological basis of reward (series title: topics in experimental psychopharmacology). Clarendon Press, New York, pp 14–65Google Scholar
  43. 43.
    Fouriezos G, Wise RA (1984) Current-distance relation for rewarding brain stimulation. Behav Brain Res 14:85–89PubMedGoogle Scholar
  44. 44.
    Fechner GT, Adler HE, Howes DH, Borin EG (1966) Elements of psychophysics, vol 1. Holt Rinehart & Winston, New YorkGoogle Scholar
  45. 45.
    Amitai N, Semenova S, Markou A (2009) Clozapine attenuates disruptions in response inhibition and task efficiency induced by repeated phencyclidine administration in the intracranial self-stimulation procedure. Eur J Pharmacol 602:78–84PubMedGoogle Scholar
  46. 46.
    Kornetsky C (1985) Brain-stimulation reward: a model for the neuronal bases for drug-induced euphoria. NIDA Res Monogr 62:30–50PubMedGoogle Scholar
  47. 47.
    Jacques S (1979) Brain stimulation and reward: “pleasure centers” after twenty-five years. Neurosurgery 5:277–283PubMedGoogle Scholar
  48. 48.
    Kenny PJ, Markou A (2006) Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 31:1203–1211PubMedGoogle Scholar
  49. 49.
    Kenny PJ (2007) Brain reward systems and compulsive drug use. Trends Pharmacol Sci 28:135–141PubMedGoogle Scholar
  50. 50.
    Harrison AA, Gasparini F, Markou A (2002) Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology (Berl) 160:56–66Google Scholar
  51. 51.
    Kokkinidis L, Zacharko RM (1980) Intracranial self-stimulation in mice using a modified hole-board task: effects of d-amphetamine. Psychopharmacology (Berl) 68:169–171Google Scholar
  52. 52.
    Schaefer GJ, Michael RP (1986) Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal. Pharmacol Biochem Behav 25:1263–1269PubMedGoogle Scholar
  53. 53.
    Markou A, Koob GF (1991) Postcocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacology 4:17–26PubMedGoogle Scholar
  54. 54.
    Schulteis G, Markou A, Cole M, Koob GF (1995) Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci USA 92:5880–5884PubMedGoogle Scholar
  55. 55.
    Epping-Jordan MP, Watkins SS, Koob GF, Markou A (1998) Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393:76–79PubMedGoogle Scholar
  56. 56.
    Spielewoy C, Markou A (2003) Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function. Neuropsychopharmacology 28:1106–1116PubMedGoogle Scholar
  57. 57.
    Kenny PJ, Chen SA, Kitamura O, Markou A, Koob GF (2006) Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci 26:5894–5900PubMedGoogle Scholar
  58. 58.
    Olds J (1956) A preliminary mapping of electrical reinforcing effects in the rat brain. J Comp Physiol Psychol 49:281–285PubMedGoogle Scholar
  59. 59.
    Olds ME, Olds J (1963) Pharmacological patterns in subcortical reinforcement behavior. Int J Neuropharmacol 2:309–325PubMedGoogle Scholar
  60. 60.
    Millhouse OE (1969) A Golgi study of the desending medial forebrain bundle. Brain Res 15:341–363PubMedGoogle Scholar
  61. 61.
    Morgane PJ (1962) Dissociation of hypothalamic self-stimulation and primary “feeding system”. Clin Res 10:185Google Scholar
  62. 62.
    Stein L (1964) Self-stimulation of the brain and the central stimulant action of amphetamine. Fed Proc 23:836–850PubMedGoogle Scholar
  63. 63.
    Stein L (1968) Chemistry of reward and ­punishment. In: Efron DH (ed) Psycho-pharmacology, a review of progress, 1957–1967. US Government Printing Office, Washington, DC, pp 105–123Google Scholar
  64. 64.
    Olds J, Allan WS, Briese E (1971) Differentiation of hypothalamic drive and reward centers. Am J Physiol 221:368–375PubMedGoogle Scholar
  65. 65.
    Phillips AG, Fibiger HC (1989) Neuroana-tomical basis of intracranial self-stimulation reward: untangling the Gordian Knot. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward (series title: Topics in experimental psychopharmacology). Oxford University Press, New York, pp 66–105Google Scholar
  66. 66.
    Miliaressis E, Thoa NB, Tizabi Y, Jacobowitz DM (1975) Catecholamine concentration of discrete brain areas following self-stimulation in the ventromedial tegmentum of the rat. Brain Res 100:192–197PubMedGoogle Scholar
  67. 67.
    Wurtz RH, Olds J (1963) Amygdaloid stimulation and operant reinforcement in the rat. J Comp Physiol Psychol 56:941–949PubMedGoogle Scholar
  68. 68.
    Miliaressis E, Bouchard A, Jacobowitz DM (1975) Strong positive reward in median raphe: specific inhibition by para-chlorophenylalanine. Brain Res 98:194–201PubMedGoogle Scholar
  69. 69.
    Tzschentke TM (2000) The medial prefrontal cortex as a part of the brain reward system. Amino Acids 19:211–219PubMedGoogle Scholar
  70. 70.
    Routtenberg A, Sloan M (1972) Self-stimulation in the frontal cortex of Rattus norvegicus. Behav Biol 7:567–572PubMedGoogle Scholar
  71. 71.
    Mora F, Phillips AG, Koolhaas JM, Rolls ET (1976) Prefrontal cortex and neostriatum self-stimulation in the rat: differential effects produced by apomorphine. Brain Res Bull 1:421–424PubMedGoogle Scholar
  72. 72.
    Corbett D, Laferriere A, Milner PM (1982) Elimination of medial prefrontal cortex self-stimulation following transection of efferents to the sulcal cortex in the rat. Physiol Behav 29:425–431PubMedGoogle Scholar
  73. 73.
    Corbett D, Laferriere A, Milner PM (1982) Plasticity of the medial prefrontal cortex: facilitated acquisition of intracranial self-stimulation by pretraining stimulation. Physiol Behav 28:531–534PubMedGoogle Scholar
  74. 74.
    Ursin R, Ursin H, Olds J (1966) Self-stimulation of hippocampus in rats. J Comp Physiol Psychol 61:353–359PubMedGoogle Scholar
  75. 75.
    Crow TJ, Spear PJ, Arbuthnott GW (1972) Intracranial self-stimulation with electrodes in the region of the locus coeruleus. Brain Res 36:275–287PubMedGoogle Scholar
  76. 76.
    van der Kooy D, Phillips AG (1977) Trigeminal substrates of intracranial self-stimulation in the brainstem. Science 196:447–449PubMedGoogle Scholar
  77. 77.
    Phillips AG (1970) Enhancement and inhibition of olfactory bulb self-stimulation by odours. Physiol Behav 5:1127–1131PubMedGoogle Scholar
  78. 78.
    Ball GG, Micco DJ Jr, Bernston GG (1974) Cerebellar stimulation in the rat: complex stimulation-bound oral behaviors and self-stimulation. Physiol Behav 13:123–127PubMedGoogle Scholar
  79. 79.
    Corbett D, Fox E, Milner PM (1982) Fiber pathways associated with cerebellar self-stimulation in the rat: a retrograde and anterograde tracing study. Behav Brain Res 6:167–184PubMedGoogle Scholar
  80. 80.
    Watson PJ (1978) Behavior maintained by electrical stimulation of the rat cerebellum. Physiol Behav 21:749–755PubMedGoogle Scholar
  81. 81.
    Olds J (1977) Drives and reinforcements: behavioral studies of hypothalamic function. Raven, New YorkGoogle Scholar
  82. 82.
    Berridge KC, Robinson TE (2003) Parsing reward. Trends Neurosci 26:507–513PubMedGoogle Scholar
  83. 83.
    Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481–1489 [erratum: 9(7):979]PubMedGoogle Scholar
  84. 84.
    Schultz W (2006) Behavioral theories and the neurophysiology of reward. Annu Rev Psychol 57:87–115PubMedGoogle Scholar
  85. 85.
    Kuczenski R (1977) Biphasic effects of amphetamine on striatal dopamine dynamics. Eur J Pharmacol 46:249–257PubMedGoogle Scholar
  86. 86.
    Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5278PubMedGoogle Scholar
  87. 87.
    Harrison AA, Parsons LH, Koob GF, Markou A (1999) RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist. Psychopharmacology (Berl) 141:242–250Google Scholar
  88. 88.
    Vorel SR, Liu X, Hayes RJ, Spector JA, Gardner EL (2001) Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 292:1175–1178PubMedGoogle Scholar
  89. 89.
    Kelley SP, Hodge CW (2003) The 5-HT3 antagonist Y-25130 blocks cocaine-induced lowering of ICSS reward thresholds in the rat. Pharmacol Biochem Behav 74:297–302PubMedGoogle Scholar
  90. 90.
    Di Chiara G, Bassareo V, Fenu S et al (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neurophar­macology 47(Suppl 1):227–241PubMedGoogle Scholar
  91. 91.
    Filip M, Frankowska M, Zaniewska M, Golda A, Przegalinski E (2005) The serotonergic system and its role in cocaine addiction. Pharmacol Rep 57:685–700PubMedGoogle Scholar
  92. 92.
    Esposito RU, Perry W, Kornetsky C (1980) Effects of d-amphetamine and naloxone on brain stimulation reward. Psychopharmacol­ogy (Berl) 69:187–191Google Scholar
  93. 93.
    Kornetsky C, Esposito RU (1981) Reward and detection thresholds for brain stimulation: dissociative effects of cocaine. Brain Res 209:496–500PubMedGoogle Scholar
  94. 94.
    Phillips AG, Fibiger HC (1973) Dopaminergic and noradrenergic substrates of positive reinforcement: differential effects of d- and l-amphetamine. Science 179:575–577PubMedGoogle Scholar
  95. 95.
    Franklin KB, Robertson A (1980) 5HT blockade and the stimulant effects of D- and L-amphetamine: no interaction in self-stimulation of prefrontal cortex, hypothalamus, or dorsal tegmentum. Unexpected lethality in hippocampal sites. Pharmacol Biochem Behav 13:365–370PubMedGoogle Scholar
  96. 96.
    Gallistel CR, Karras D (1984) Pimozide and amphetamine have opposing effects on the reward summation function. Pharmacol Biochem Behav 20:73–77PubMedGoogle Scholar
  97. 97.
    Leith NJ, Barrett RJ (1981) Self-stimulation and amphetamine: tolerance to d and l isomers and cross tolerance to cocaine and methylphenidate. Psychopharmacology (Berl) 74:23–28Google Scholar
  98. 98.
    Anderson JL, Leith NJ, Barrett RJ (1978) Tolerance to amphetamine’s facilitation of self-stimulation responding: anatomical specificity. Brain Res 145:37–48PubMedGoogle Scholar
  99. 99.
    Leith NJ, Barrett RJ (1976) Amphetamine and the reward system: evidence for tolerance and post-drug depression. Psychophar­macologia 46:19–25PubMedGoogle Scholar
  100. 100.
    Liebman JM, Segal DS (1976) Lack of ­tolerance or sensitization to the effects of chronic d-amphetamine on substantia nigra self-­stimulation. Behav Biol 16:211–220PubMedGoogle Scholar
  101. 101.
    Wauquier A, Niemergeers CJ (1974) Intracranial self-stimulation in rats as a ­function of various stimulus parameters: V. Influence of cocaine on medial forebrain bundle stimulation with monopolar electrodes. Psychopharmacologia 38:201–210PubMedGoogle Scholar
  102. 102.
    Phillips AG, Broekkamp CL, Fibiger HC (1983) Strategies for studying the neurochemical substrates of drug reinforcement in rodents. Prog Neuropsychopharmacol Biol Psychiatry 7:585–590PubMedGoogle Scholar
  103. 103.
    Frank RA, Pommering T, Nitz D (1988) The interactive effects of cocaine and imipramine on self-stimulation train-duration thresholds. Pharmacol Biochem Behav 30:1–4PubMedGoogle Scholar
  104. 104.
    van Wolfswinkel L, Seifert WF, van Ree JM (1988) Catecholamines and endogenous opioids in ventral tegmental self-stimulation reward. Pharmacol Biochem Behav 30:589–595PubMedGoogle Scholar
  105. 105.
    Kokkinidis L, McCarter BD (1990) Postco-caine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects. Pharmacol Biochem Behav 36:463–471PubMedGoogle Scholar
  106. 106.
    Moody CA, Frank RA (1990) Cocaine facilitates prefrontal cortex self-stimulation. Pharmacol Biochem Behav 35:743–746PubMedGoogle Scholar
  107. 107.
    Corbett D (1991) Cocaine enhances the reward value of medial prefrontal cortex self-stimulation. NeuroReport 2:805–808PubMedGoogle Scholar
  108. 108.
    Williams HP, Manderscheid PZ, Schwartz M, Frank RA (1991) Cocaine’s effects on rate of intracranial self-stimulation. Pharmacol Biochem Behav 40:273–277PubMedGoogle Scholar
  109. 109.
    Markou A, Koob GF (1992) Bromocriptine reverses the elevation in intracranial self-stimulation thresholds observed in a rat model of cocaine withdrawal. Neuropsycho­pharmacology 7:213–224PubMedGoogle Scholar
  110. 110.
    Kling-Petersen T, Ljung E, Svensson K (1994) The preferential dopamine autoreceptor antagonist (+)-UH232 antagonizes the positive reinforcing effects of cocaine and d-amphetamine in the ICSS paradigm. Pharmacol Biochem Behav 49:345–351PubMedGoogle Scholar
  111. 111.
    Maldonado-Irizarry CS, Stellar JR, Kelley AE (1994) Effects of cocaine and GBR-12909 on brain stimulation reward. Pharmacol Biochem Behav 48:915–920PubMedGoogle Scholar
  112. 112.
    Panagis G, Spyraki C (1996) Neurophar­macological evidence for the role of do-pamine in ventral pallidum self-stimulation. Psychopharmacology (Berl) 123:280–288Google Scholar
  113. 113.
    Kita K, Shiratani T, Takenouchi K, Fukuzako H, Takigawa M (1999) Effects of D1 and D2 dopamine receptor antagonists on cocaine-induced self-stimulation and locomotor activity in rats. Eur Neuropsychopharmacol 9:1–7PubMedGoogle Scholar
  114. 114.
    Panagis G, Kastellakis A, Spyraki C, Nomikos G (2000) Effects of methyllycaconitine (MLA), an α7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward. Psychophar­macology (Berl) 149:388–396Google Scholar
  115. 115.
    Gilliss B, Malanga CJ, Pieper JO, Carlezon WA Jr (2002) Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice. Psychopharmacology (Berl) 163:238–248Google Scholar
  116. 116.
    Kenny PJ, Koob GF, Markou A (2003) Conditioned facilitation of brain reward function after repeated cocaine administration. Behav Neurosci 117:1103–1107PubMedGoogle Scholar
  117. 117.
    Kenny PJ, Paterson NE, Boutrel B et al (2003) Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats. Ann NY Acad Sci 1003:415–418PubMedGoogle Scholar
  118. 118.
    Hayes RJ, Gardner EL (2004) The basolateral complex of the amygdala mediates the modulation of intracranial self-stimulation threshold by drug-associated cues. Eur J Neurosci 20:273–280PubMedGoogle Scholar
  119. 119.
    Kenny PJ, Boutrel B, Gasparini F, Koob GF, Markou A (2005) Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats. Psychopharmacology (Berl) 179:247–254Google Scholar
  120. 120.
    Mague SD, Andersen SL, Carlezon WA Jr (2005) Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats. Biol Psychiatry 57:120–125PubMedGoogle Scholar
  121. 121.
    Slattery DA, Markou A, Froestl W, Cryan JF (2005) The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology 30:2065–2072PubMedGoogle Scholar
  122. 122.
    Hernandez G, Haines E, Shizgal P (2008) Potentiation of intracranial self-stimulation during prolonged subcutaneous infusion of cocaine. J Neurosci Methods 175:79–87PubMedGoogle Scholar
  123. 123.
    Tomasiewicz HC, Todtenkopf MS, Chartoff EH, Cohen BM, Carlezon WA Jr (2008) The kappa-opioid agonist U69, 593 blocks cocaine-induced enhancement of brain stimulation reward. Biol Psychiatry 64:982–988PubMedGoogle Scholar
  124. 124.
    Vlachou S, Stamatopoulou F, Nomikos GG, Panagis G (2008) Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the ­reinforcing and psychostimulant effects of cocaine. Int J Neuropsychopharmacol 11:905–923PubMedGoogle Scholar
  125. 125.
    Crow TJ (1970) Enhancement of cocaine intra-cranial self-stimulation in the rat. Life Sci 9:375–381PubMedGoogle Scholar
  126. 126.
    Frank RA, Manderscheid PZ, Panicker S, Williams HP, Kokoris D (1992) Cocaine euphoria, dysphoria, and tolerance assessed using drug-induced changes in brain-­stimulation reward. Pharmacol Biochem Behav 42:771–779PubMedGoogle Scholar
  127. 127.
    Frank RA, Zubrycki E (1989) Chronic imipramine does not block cocaine-induced increases in brain stimulation reward. Phar-macol Biochem Behav 33:725–727PubMedGoogle Scholar
  128. 128.
    Frank RA, Martz S, Pommering T (1988) The effect of chronic cocaine on self-stimulation train-duration thresholds. Pharmacol Biochem Behav 29:755–758PubMedGoogle Scholar
  129. 129.
    Kenny PJ, Polis I, Koob GF, Markou A (2003) Low dose cocaine self-administration transiently increases but high dose cocaine persistently decreases brain reward function in rats. Eur J Neurosci 17:191–195PubMedGoogle Scholar
  130. 130.
    Stratmann JA, Craft RM (1997) Intracranial self-stimulation in female and male rats: no sex differences using a rate-independent procedure. Drug Alcohol Depend 46:31–40PubMedGoogle Scholar
  131. 131.
    Markou A, Hauger RL, Koob GF (1992) Desmethylimipramine attenuates cocaine withdrawal in rats. Psychopharmacology (Berl) 109:305–314Google Scholar
  132. 132.
    Hammer RP Jr, Egilmez Y, Emmett-Oglesby MW (1997) Neural mechanisms of tolerance to the effects of cocaine. Behav Brain Res 84:225–239PubMedGoogle Scholar
  133. 133.
    Goussakov I, Chartoff EH, Tsvetkov E et al (2006) LTP in the lateral amygdala during cocaine withdrawal. Eur J Neurosci 23:239–250PubMedGoogle Scholar
  134. 134.
    Baldo BA, Koob GF, Markou A (1999) Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats. J Neurosci 19:11017–11026PubMedGoogle Scholar
  135. 135.
    Baldo BA, Markou A, Koob GF (1999) Increased sensitivity to the locomotor depressant effect of a dopamine receptor antagonist during cocaine withdrawal in the rat. Psycho­pharmacology (Berl) 141:135–144Google Scholar
  136. 136.
    Weiss F, Markou A, Lorang MT, Koob GF (1992) Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593:314–318PubMedGoogle Scholar
  137. 137.
    Robertson A, Laferriere A, Franklin KB (1981) Amphetamine and increases in ­current intensity modulate reward in the hypothalamus and substantia nigra but not in the prefrontal cortex. Physiol Behav 26:809–813PubMedGoogle Scholar
  138. 138.
    Schaefer GJ, Michael RP (1988) An analysis of the effects of amphetamine on brain self-stimulation behavior. Behav Brain Res 29:93–101PubMedGoogle Scholar
  139. 139.
    Elmer GI, Pieper JO, Levy J et al (2005) Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice. Psychopharmacology (Berl) 182:33–44Google Scholar
  140. 140.
    Hao J, Cabeza de Vaca S, Pan Y, Carr KD (2006) Effects of central leptin infusion on the reward-potentiating effect of D-amphetamine. Brain Res 1087:123–133PubMedGoogle Scholar
  141. 141.
    Hayes DJ, Clements R, Greenshaw AJ (2009) Effects of systemic and intra-nucleus accumbens 5-HT2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats. Psychopharmacology (Berl) 203(3):579–588Google Scholar
  142. 142.
    Kamens HM, Burkhart-Kasch S, McKinnon CS, Li N, Reed C, Phillips TJ (2005) Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes Brain Behav 4:110–125PubMedGoogle Scholar
  143. 143.
    Lin D, Bruijnzeel AW, Schmidt P, Markou A (2002) Exposure to chronic mild stress alters thresholds for lateral hypothalamic stimulation reward and subsequent responsiveness to amphetamine. Neuroscience 114:925–933PubMedGoogle Scholar
  144. 144.
    Sweet KL, Neill DB (1999) Amphetamine injections into the nucleus accumbens enhance the reward of stimulation of the subiculum. Ann NY Acad Sci 877:828–830PubMedGoogle Scholar
  145. 145.
    Frank RA, Tsibulsky V, Grocki S et al (1995) Mixed D2/5-HT2A antagonism of amphetamine-induced facilitation of brain stimulation reward. Pharmacol Biochem Behav 52:799–804PubMedGoogle Scholar
  146. 146.
    Olds ME, Yuwiler A (1992) Effects of acute and chronic fenfluramine on self-stimulation and its facilitation by amphetamine. Eur J Pharmacol 216:363–372PubMedGoogle Scholar
  147. 147.
    Schaefer GJ, West CH, Michael RP (1987) Self-training for brain stimulation in the medial forebrain bundle of rats: a comparison of saline with amphetamine. Behav Brain Res 24:215–220PubMedGoogle Scholar
  148. 148.
    Hand TH, Franklin KB (1983) The ­influence of amphetamine on preference for lateral hypothalamic versus prefrontal cortex or ventral tegmental area self-stimulation. Pharmacol Biochem Behav 18:695–699PubMedGoogle Scholar
  149. 149.
    Zacharko RM, Kokkinidis L (1982) Preference for fixed vs self-selected durations of brain stimulation in rats administered D-ampheta­mine sulphate. Life Sci 30:1029–1034PubMedGoogle Scholar
  150. 150.
    Franklin KB, Robertson A (1982) Effects and interactions of naloxone and amphetamine on self-stimulation of the prefrontal cortex and dorsal tegmentum. Pharmacol Biochem Behav 16:433–436PubMedGoogle Scholar
  151. 151.
    Kokkinidis L, Zacharko RM (1980) Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm. Psychopharmacology (Berl) 68:73–76Google Scholar
  152. 152.
    Robertson A, Mogenson GJ (1979) Facilitation of self-stimulation of the prefrontal cortex in rats following chronic administration of spiroperidol or amphetamine. Psychopharmacology (Berl) 65:149–154Google Scholar
  153. 153.
    Zacharko RM, Wishart TB (1979) Facilitation of self-stimulation with high doses of amphetamine in the rat. Psychopharmacology (Berl) 64:247–248Google Scholar
  154. 154.
    Koob GF, Winger GD, Meyerhoff JL, Annau Z (1977) Effects of D-amphetamine on concurrent self-stimulation of forebrain and brain stem loci. Brain Res 137:109–126PubMedGoogle Scholar
  155. 155.
    Liebman J, Segal DS (1977) Differential effects of morphine and D-amphetamine on self-stimulation from closely adjacent regions in rat midbrain. Brain Res 136:103–117PubMedGoogle Scholar
  156. 156.
    Howard JL, Pollard GT, Rohrbach KW, Harto NE (1976) Effect of β-phenylethylamine and d-amphetamine on electrical self-stimulation of brain. Pharmacol Biochem Behav 5:661–664PubMedGoogle Scholar
  157. 157.
    Cazala P (1976) Effects of d- and l-amphetamine on dorsal and ventral hypothalamic self-stimulation in three inbred strains of mice. Pharmacol Biochem Behav 5:505–510PubMedGoogle Scholar
  158. 158.
    Ellman SJ, Ackermann RF, Bodnar RJ, Jackler F, Steiner SS (1976) D- and L-amphetamine differentially mediates self-stimulation in rat dorsal midbrain area. Physiol Behav 16:1–7PubMedGoogle Scholar
  159. 159.
    Olds ME (1972) Comparative effects of amphetamine, scopolamine and clordiaze-poxide on self-stimulation behavior. Rev Can Biol 31(Suppl):25–47PubMedGoogle Scholar
  160. 160.
    Leith NJ, Barrett RJ (1980) Effects of chronic amphetamine or reserpine on self-stimulation responding: animal model of depression? Psychopharmacology (Berl) 72:9–15Google Scholar
  161. 161.
    Predy PA, Kokkinidis L (1981) Post-amphetamine depression of self-stimulation behavior in rats: prophylactic effects of lithium. Neurosci Lett 23:343–347PubMedGoogle Scholar
  162. 162.
    Borowski TB, Kokkinidis L (1992) Long-term influence of d-amphetamine on mesolimbic brain-stimulation reward: comparison to chronic haloperidol and naloxone effects. Pharmacol Biochem Behav 43:1–15PubMedGoogle Scholar
  163. 163.
    Paterson NE, Myers C, Markou A (2000) Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology (Berl) 152:440–446Google Scholar
  164. 164.
    Harrison AA, Liem YT, Markou A (2001) Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmaco­logy 25:55–71PubMedGoogle Scholar
  165. 165.
    Barr AM, Markou A, Phillips AG (2002) A “crash” course on psychostimulant withdrawal as a model of depression. Trends Pharmacol Sci 23:475–482PubMedGoogle Scholar
  166. 166.
    Cryan JF, Hoyer D, Markou A (2003) Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol Psychiatry 54:49–58PubMedGoogle Scholar
  167. 167.
    Markou A, Harrison AA, Chevrette J, Hoyer D (2005) Paroxetine combined with a 5-HT1A receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats. Psychopharmacology (Berl) 178:133–142Google Scholar
  168. 168.
    Wise RA, Munn E (1995) Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds. Psychopharmacology (Berl) 117:130–136Google Scholar
  169. 169.
    Kokkinidis L, Zacharko RM, Anisman H (1986) Amphetamine withdrawal: a behavioral evaluation. Life Sci 38:1617–1623PubMedGoogle Scholar
  170. 170.
    Cassens G, Actor C, Kling M, Schildkraut JJ (1981) Amphetamine withdrawal: effects on threshold of intracranial reinforcement. Psychopharmacology (Berl) 73:318–322Google Scholar
  171. 171.
    Simpson DM, Annau Z (1977) Behavioral withdrawal following several psychoactive drugs. Pharmacol Biochem Behav 7:59–64PubMedGoogle Scholar
  172. 172.
    Barr AM, Zis AP, Phillips AG (2002) Repeated electroconvulsive shock attenuates the depressive-like effects of d-amphetamine withdrawal on brain reward function in rats. Psychopharmacology (Berl) 159:196–202Google Scholar
  173. 173.
    Lin D, Koob GF, Markou A (1999) Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat: interactions between the two drugs. Psychopharmacology (Berl) 145:283–294Google Scholar
  174. 174.
    Takigawa M, Maeda H, Ueyama K, Tominaga H, Matsumoto K (1993) A dual approach to self-stimulation and locomotor trace affected by chronic methamphetamine treatment for an animal model of schizophrenia. Can J Physiol Pharmacol 71:321–325PubMedGoogle Scholar
  175. 175.
    Sagara H, Kitamura Y, Sendo T, Araki H, Gomita Y (2008) Motivational effects of methamphetamine as measured by the runway method using priming stimulation of intracranial self-stimulation behavior. Biol Pharm Bull 31:541–545PubMedGoogle Scholar
  176. 176.
    Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychophar­macology (Berl) 117:2–10, ­discussion 4-20Google Scholar
  177. 177.
    Clarke PBS, Kumar R (1984) Effects of nicotine and d-amphetamine on intracranial self-stimulation in a shuttle box test in rats. Psychopharmacology (Berl) 84:109–114Google Scholar
  178. 178.
    Schaefer GJ, Michael RP (1986) Task-specific effects of nicotine in rats: intracranial self-stimulation and locomotor activity. Neuro­pharmacology 25:125–131PubMedGoogle Scholar
  179. 179.
    Arregui-Aguirre A, Claro-Izaguirre F, Goni-Garrido MJ, Zarate-Oleaga JA, Morgado-Bernal I (1987) Effects of acute nicotine and ethanol on medial prefrontal cortex self-stimulation in rats. Pharmacol Biochem Behav 27:15–20PubMedGoogle Scholar
  180. 180.
    Bespalov A, Lebedev A, Panchenko G, Zvartau E (1999) Effects of abused drugs on thresholds and breaking points of intracranial self-stimulation in rats. Eur Neuropsycho­pharmacol 9:377–383PubMedGoogle Scholar
  181. 181.
    Huston-Lyons D, Sarkar M, Kornetsky C (1993) Nicotine and brain-stimulation reward: interactions with morphine, amphetamine and pimozide. Pharmacol Biochem Behav 46:453–457PubMedGoogle Scholar
  182. 182.
    Kenny PJ, Chartoff E, Roberto M, Carlezon WA Jr, Markou A (2009) NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala. Neuropsychopharmacology 34:266–281PubMedGoogle Scholar
  183. 183.
    Paterson NE, Balfour DJ, Markou A (2008) Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats. Nicotine Tob Res 10:995–1008PubMedGoogle Scholar
  184. 184.
    Paterson NE, Vlachou S, Guery S, Kaupmann K, Froestl W, Markou A (2008) Positive modulation of GABAB receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. J Pharmacol Exp Ther 326:306–314PubMedGoogle Scholar
  185. 185.
    Sagara H, Kitamura Y, Esumi S, Sendo T, Araki H, Gomita Y (2008) Motivational effects of nicotine as measured by the runway method using priming stimulation of intra-cranial self-stimulation behavior. Acta Med Okayama 62:227–233PubMedGoogle Scholar
  186. 186.
    Herberg LJ, Montgomery AM, Rose IC (1993) Tolerance and sensitization to stimulant and depressant effects of nicotine in intracranial self-stimulation in the rat. Behav Pharmacol 4:419–427PubMedGoogle Scholar
  187. 187.
    Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393:295–314PubMedGoogle Scholar
  188. 188.
    Schaefer GJ, Michael RP (1992) Interactions between alcohol and nicotine on intracranial self-stimulation and locomotor activity in rats. Drug Alcohol Depend 30:37–47PubMedGoogle Scholar
  189. 189.
    Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ (2008) Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci USA 105:19480–19485PubMedGoogle Scholar
  190. 190.
    Malin DH, Lake JR, Newlin-Maultsby P et al (1992) Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 43:779–784PubMedGoogle Scholar
  191. 191.
    Malin DH, Lake JR, Carter VA, Cunningham JS, Wilson OB (1993) Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology (Berl) 112:339–342Google Scholar
  192. 192.
    Malin DH, Lake JR, Carter VA et al (1994) The nicotinic antagonist mecamylamine ­precipitates nicotine abstinence syndrome in the rat. Psychopharmacology (Berl) 115:180–184Google Scholar
  193. 193.
    Hildebrand BE, Panagis G, Svensson TH, Nomikos GG (1999) Behavioral and ­biochemical manifestations of mecamylamine-­precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral ­tegmental area. Neuropsychopharmacology 21:560–574PubMedGoogle Scholar
  194. 194.
    Markou A, Paterson NE (2001) The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine Tob Res 3:361–373PubMedGoogle Scholar
  195. 195.
    Bruijnzeel AW, Markou A (2004) Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats. Neurophar­macology 47:572–579PubMedGoogle Scholar
  196. 196.
    Johnson PM, Hollander JA, Kenny PJ (2008) Decreased brain reward function during ­nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies. Pharmacol Biochem Behav 90:409–415PubMedGoogle Scholar
  197. 197.
    Jonkman S, Risbrough VB, Geyer MA, Markou A (2008) Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology 33:2131–2138PubMedGoogle Scholar
  198. 198.
    Stoker AK, Semenova S, Markou A (2008) Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6 J and BALB/cByJ mice. Neuro-pharmacology 54:1223–1232PubMedGoogle Scholar
  199. 199.
    Watkins SS, Stinus L, Koob GF, Markou A (2000) Reward and somatic changes during precipitated nicotine withdrawal in rats: ­centrally and peripherally mediated effects. J Pharmacol Exp Ther 292:1053–1064PubMedGoogle Scholar
  200. 200.
    Kenny PJ, Markou A (2001) Neurobiology of the nicotine withdrawal syndrome. Pharmacol Biochem Behav 70:531–549PubMedGoogle Scholar
  201. 201.
    Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology (Berl) 50:35–39Google Scholar
  202. 202.
    LeSage MG, Burroughs D, Pentel PR (2006) Effects of nicotine withdrawal on performance under a progressive-ratio schedule of sucrose pellet delivery in rats. Pharmacol Biochem Behav 83:585–591PubMedGoogle Scholar
  203. 203.
    Jonkman S, Markou A (2006) Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats. Neurosci Lett 400:140–145PubMedGoogle Scholar
  204. 204.
    O’Dell LE, Bruijnzeel AW, Smith RT et al (2006) Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction. Psychopharmacology (Berl) 186:612–619Google Scholar
  205. 205.
    Liechti ME, Markou A (2007) Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats. Biochem Pharmacol 74:1299–1307PubMedGoogle Scholar
  206. 206.
    Liechti ME, Markou A (2007) Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats. Eur J Pharmacol 554:164–174PubMedGoogle Scholar
  207. 207.
    Paterson NE, Semenova S, Markou A (2008) The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat. Psychophar­macology (Berl) 198:351–362Google Scholar
  208. 208.
    Rylkova D, Boissoneault J, Isaac S, Prado M, Shah HP, Bruijnzeel AW (2008) Effects of NPY and the specific Y1 receptor agonist [D-His26]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats. Neuropeptides 42:215–227PubMedGoogle Scholar
  209. 209.
    Kenny PJ, Markou A (2005) Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems. J Neurosci 25:6208–6212PubMedGoogle Scholar
  210. 210.
    Panagis G, Kastellakis A, Spyraki C (1998) Involvement of the ventral tegmental area opiate receptors in self-stimulation elicited from the ventral pallidum. Psychophar­macology (Berl) 139:222–229Google Scholar
  211. 211.
    Paterson NE, Balfour DJ, Markou A (2007) Chronic bupropion attenuated the anhe-donic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. Eur J Neurosci 25:3099–3108PubMedGoogle Scholar
  212. 212.
    Fowler CD, Arends MA, Kenny PJ (2008) Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. Behav Pharmacol 19:461–484PubMedGoogle Scholar
  213. 213.
    Ivanova S, Greenshaw AJ (1997) Nicotine-induced decreases in VTA electrical self-stimulation thresholds: blockade by haloperidol and mecamylamine but not scopolamine or ondansetron. Psychopharmacology (Berl) 134:187–192Google Scholar
  214. 214.
    Hildebrand BE, Nomikos GG, Hertel P, Schilstrom B, Svensson TH (1998) Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated ­nicotine withdrawal syndrome. Brain Res 779:214–225PubMedGoogle Scholar
  215. 215.
    Hildebrand BE, Svensson TH (2000) Intraaccumbal mecamylamine infusion does not affect dopamine output in the nucleus accumbens of chronically nicotine-treated rats. J Neural Transm 107:861–872PubMedGoogle Scholar
  216. 216.
    Cryan JF, Bruijnzeel AW, Skjei KL, Markou A (2003) Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology (Berl) 168:347–358Google Scholar
  217. 217.
    Kenny PJ, Gasparini F, Markou A (2003) Group II metabotropic and α-amino-3-­hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J Pharmacol Exp Ther 306:1068–1076PubMedGoogle Scholar
  218. 218.
    Bruijnzeel AW, Zislis G, Wilson C, Gold MS (2007) Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology 32:955–963PubMedGoogle Scholar
  219. 219.
    Marcinkiewcz CA, Prado MM, Isaac SK, Marshall A, Rylkova D, Bruijnzeel AW (2009) Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the ­negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology 34(7):1743–1752PubMedGoogle Scholar
  220. 220.
    Balfour DJ (2002) Neuroplasticity within the mesoaccumbens dopamine system and its role in tobacco dependence. Curr Drug Targets CNS Neurol Disord 1:413–421PubMedGoogle Scholar
  221. 221.
    Wauquier A, Niemegeers CJ (1976) Intracra-nial self-stimulation in rats as a function of various stimulus parameters: VI. Influence of fentanyl, piritramide, and morphine on medial forebrain bundle ­stimulation with monopolar electrodes. Psychopharmacologia 46:179–183PubMedGoogle Scholar
  222. 222.
    Seeger TF, Nazzaro JM, Gardner EL (1980) Selective inhibition of mesolimbic behavioral supersensitivity by naloxone. Eur J Pharmacol 65:435–438PubMedGoogle Scholar
  223. 223.
    Hand TH, Franklin KB (1985) 6-OHDA lesions of the ventral tegmental area block morphine-induced but not amphetamine-induced facilitation of self-stimulation. Brain Res 328:233–241PubMedGoogle Scholar
  224. 224.
    van Wolfswinkel L, van Ree JM (1985) Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation. Naunyn Schmiedebergs Arch Pharmacol 330:84–92PubMedGoogle Scholar
  225. 225.
    Hand TH, Franklin KB (1986) Associative factors in the effects of morphine on self-stimulation. Psychopharmacology (Berl) 88:472–479Google Scholar
  226. 226.
    Esposito R, Kornetsky C (1977) Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration. Science 195:189–191PubMedGoogle Scholar
  227. 227.
    Esposito RU, McLean S, Kornetsky C (1979) Effects of morphine on intracranial self-stimulation to various brain stem loci. Brain Res 168:425–429PubMedGoogle Scholar
  228. 228.
    Bozarth MA, Gerber GJ, Wise RA (1980) Intracranial self-stimulation as a technique to study the reward properties of drugs of abuse. Pharmacol Biochem Behav 13(Suppl 1):245–247PubMedGoogle Scholar
  229. 229.
    Nazzaro JM, Seeger TF, Gardner EL (1981) Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds. Pharmacol Biochem Behav 14:325–331PubMedGoogle Scholar
  230. 230.
    Hubner CB, Kornetsky C (1992) Heroin, 6-acetylmorphine and morphine effects on threshold for rewarding and aversive brain stimulation. J Pharmacol Exp Ther 260:562–567PubMedGoogle Scholar
  231. 231.
    Holtzman SG (1976) Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat. Psychopharmacologia 46:223–227PubMedGoogle Scholar
  232. 232.
    Schaefer GJ, Holtzman SG (1977) Dose- and time-dependent effects of narcotic analgesics on intracranial self-stimulation in the rat. Psychopharmacology (Berl) 53:227–234Google Scholar
  233. 233.
    Jackler F, Steiner SS, Bodnar RJ, Ackermann RF, Nelson WT, Ellman SJ (1979) Morphine and intracranial self-stimulation in the hypothalamus and dorsal brainstem: differential effects of dose, time and site. Int J Neurosci 9:21–35PubMedGoogle Scholar
  234. 234.
    Weibel SL, Wolf HH (1979) Opiate modification of intracranial self-stimulation in the rat. Pharmacol Biochem Behav 10:71–78PubMedGoogle Scholar
  235. 235.
    Bermudez-Rattoni F, Cruz-Morales S, Reid LD (1983) Addictive agents and intracranial stimulation (ICS): novel antagonists and agonists of morphine and pressing for ICS. Pharmacol Biochem Behav 18:777–784PubMedGoogle Scholar
  236. 236.
    Weeks JR (1962) Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats. Science 138:143–144PubMedGoogle Scholar
  237. 237.
    Thompson T, Schuster CR (1964) Morphine self-administration, food-reinforced, and avoidance behaviors in rhesus monkeys. Psychopharmacologia 5:87–94PubMedGoogle Scholar
  238. 238.
    Schaefer GJ, Michael RP (1990) Interactions of naloxone with morphine, amphetamine and phencyclidine on fixed interval ­responding for intracranial self-stimulation in rats. Psychopharmacology (Berl) 102:263–268Google Scholar
  239. 239.
    Koob GF, Spector NH, Meyerhoff JL (1975) Effects of heroin on lever pressing for intracranial self-stimulation, food and water in the rat. Psychopharmacologia 42:231–234PubMedGoogle Scholar
  240. 240.
    Gerber GJ, Bozarth MA, Spindler JE, Wise RA (1985) Concurrent heroin self-administration and intracranial self-stimulation in rats. Pharmacol Biochem Behav 23:837–842PubMedGoogle Scholar
  241. 241.
    van der Kooy D, Schiff BB, Steele D (1978) Response-dependent effects of morphine on reinforcing lateral hypothalamic self-stimulation. Psychopharmacology (Berl) 58:63–67Google Scholar
  242. 242.
    Bespalov A, Dumpis M, Piotrovsky L, Zvartau E (1994) Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine. Eur J Pharmacol 264:233–239PubMedGoogle Scholar
  243. 243.
    Easterling KW, Holtzman SG (1997) Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists. J Pharmacol Exp Ther 281:188–199PubMedGoogle Scholar
  244. 244.
    Easterling KW, Plovnick RM, Holtzman SG (2000) Acute opioid but not benzodiazepine dependence in rats responding for intracranial self-stimulation. Psychopharmacology (Berl) 148:263–271Google Scholar
  245. 245.
    Easterling KW, Holtzman SG (2004) In rats, acute morphine dependence results in antagonist-induced response suppression of intra-cranial self-stimulation. Psychopharmacology (Berl) 175:287–295Google Scholar
  246. 246.
    Schulteis G, Markou A, Gold LH, Stinus L, Koob GF (1994) Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 271:1391–1398PubMedGoogle Scholar
  247. 247.
    Meyer DR, Sparber SB (1977) Evidence of possible opiate dependence during the behavioral depressant action of a single dose of morphine. Life Sci 21:1087–1093PubMedGoogle Scholar
  248. 248.
    Young AM (1986) Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone. Psychophar­macology (Berl) 88:201–208Google Scholar
  249. 249.
    Adams JU, Holtzman SG (1990) Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats. J Pharmacol Exp Ther 253:483–489PubMedGoogle Scholar
  250. 250.
    Bruijnzeel AW, Marcinkiewcz C, Isaac S, Booth MM, Dennis DM, Gold MS (2007) The effects of buprenorphine on fentanyl withdrawal in rats. Psychopharmacology (Berl) 191:931–941Google Scholar
  251. 251.
    Gardner EL, Paredes W, Smith D et al (1988) Facilitation of brain stimulation reward by Δ9-tetrahydrocannabinol. Psychopharmacology (Berl) 96:142–144Google Scholar
  252. 252.
    Lepore M, Liu X, Savage V, Matalon D, Gardner EL (1996) Genetic differences in Δ9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains. Life Sci 58:PL365–PL372PubMedGoogle Scholar
  253. 253.
    Gardner EL, Vorel SR (1998) Cannabinoid transmission and reward-related events. Neurobiol Dis 5:502–533PubMedGoogle Scholar
  254. 254.
    Gardner EL, Vorel SR (1989) Facilitation of brain stimulation reward by Δ9-tetrahydrocannabinol is mediated by an endogenous opioid mechanism. Adv Biosci 75:4Google Scholar
  255. 255.
    Stark P, Dews PB (1980) Cannabinoids: II. Cardiovascular effects. J Pharmacol Exp Ther 214:131–138PubMedGoogle Scholar
  256. 256.
    Kucharski LT, Williams JE, Kornetsky C (1983) The effects of levonantradol on rewarding brain stimulation thresholds in the rat. Pharmacol Biochem Behav 19:149–151PubMedGoogle Scholar
  257. 257.
    Vlachou S, Nomikos GG, Stephens DN, Panagis G (2007) Lack of evidence for appetitive effects of Δ9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents. Behav Pharmacol 18:311–319PubMedGoogle Scholar
  258. 258.
    Stark P, Dews PB (1980) Cannabinoids: I Behavioral effects. J Pharmacol Exp Ther 214:124–130PubMedGoogle Scholar
  259. 259.
    Arnold JC, Hunt GE, McGregor IS (2001) Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats. Life Sci 70:97–108PubMedGoogle Scholar
  260. 260.
    Antoniou K, Galanopoulos A, Vlachou S et al (2005) Behavioral pharmacological properties of a novel cannabinoid 1’,1’-ditheolane D8-THC analog, AMG-3. Behav Pharmacol 16:499–510PubMedGoogle Scholar
  261. 261.
    Vlachou S, Nomikos GG, Panagis G (2005) CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat. Psychopharmacology (Berl) 179:498–508Google Scholar
  262. 262.
    Vlachou S, Nomikos GG, Panagis G (2003) WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation. Behav Brain Res 141:215–222PubMedGoogle Scholar
  263. 263.
    Vlachou S, Nomikos GG, Panagis G (2006) Effects of endocannabinoid neurotransmission modulators on brain stimulation reward. Psychopharmacology (Berl) 188:293–305Google Scholar
  264. 264.
    Deroche-Gamonet V, Le Moal M, Piazza PV, Soubrie P (2001) SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain ­stimulation in rats. Psychopharmacology (Berl) 157:254–259Google Scholar
  265. 265.
    Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370:1706–1713PubMedGoogle Scholar
  266. 266.
    Green B, Kavanagh D, Young R (2003) Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev 22:453–460PubMedGoogle Scholar
  267. 267.
    Gregg JM, Small EW, Moore R, Raft D, Toomey TC (1976) Emotional response to intravenous delta9tetrahydrocannabinol during oral surgery. J Oral Surg 34:301–313PubMedGoogle Scholar
  268. 268.
    McCabe M, Smith FP, Macdonald JS, Woolley PV, Goldberg D, Schein PS (1988) Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy. Invest New Drugs 6:243–246PubMedGoogle Scholar
  269. 269.
    De Witte P (1982) Brain stimulation as the reinforcer in alcohol-saline discrimination. Pharmacol Biochem Behav 17:1093–1096PubMedGoogle Scholar
  270. 270.
    De Witte P, Bada MF (1983) Self-stimulation and alcohol administered orally or intraperitoneally. Exp Neurol 82:675–682PubMedGoogle Scholar
  271. 271.
    Moolten M, Kornetsky C (1990) Oral self-administration of ethanol and not experimenter-administered ethanol facilitates rewarding electrical brain stimulation. Alcohol 7:221–225PubMedGoogle Scholar
  272. 272.
    Carlson RH, Lydic R (1976) The effects of ethanol upon threshold and response rate for self-stimulation. Psychopharmacology (Berl) 50:61–64Google Scholar
  273. 273.
    Routtenberg A (1981) Drug of abuse and the endogenous reinforcement system: the resistance of intracranial self-stimulation behavior to the inebriating effects of ethanol. Ann NY Acad Sci 362:60–66PubMedGoogle Scholar
  274. 274.
    Schaefer GJ, Michael RP (1987) Ethanol and current thresholds for brain self-stimulation in the lateral hypothalamus of the rat. Alcohol 4:209–213PubMedGoogle Scholar
  275. 275.
    Schaefer GJ, Michael RP (1991) Effects of an alcohol diet on locomotor activity and the acquisition of brain self-stimulation in rats. Alcohol 8:71–75PubMedGoogle Scholar
  276. 276.
    Chester JA, Rausch EJ, June HL, Froehlich JC (2006) Decreased reward during acute alcohol withdrawal in rats selectively bred for low alcohol drinking. Alcohol 38:165–172PubMedGoogle Scholar
  277. 277.
    Olds J, Travis RP (1960) Effects of chlorpromazine, meprobamate, pentobarbital and morphine on self-stimulation. J Pharmacol Exp Ther 128:397–404PubMedGoogle Scholar
  278. 278.
    Seeger TF, Carlson KR, Nazzaro JM (1981) Pentobarbital induces a naloxone-reversible decrease in mesolimbic self-stimulation threshold. Pharmacol Biochem Behav 15:583–586PubMedGoogle Scholar
  279. 279.
    Caudarella M, Campbell KA, Milgram NW (1982) Differential effects of diazepam (valium) on brain stimulation reward sites. Pharmacol Biochem Behav 16:17–21PubMedGoogle Scholar
  280. 280.
    Herberg LJ, Williams SF (1983) Anti-conflict and depressant effects by GABA agonists and antagonists, benzodiazepines and non-gabergic anticonvulsants on self-stimulation and locomotor activity. Pharmacol Biochem Behav 19:625–633PubMedGoogle Scholar
  281. 281.
    Sagara H, Kitamura Y, Sendo T, Araki H, Gomita Y (2008) Effect of diazepam on the runway method using priming stimulation of intracranial self stimulation behavior. J Pharmacol Sci 107:355–360PubMedGoogle Scholar
  282. 282.
    Domino EF, Olds ME (1972) Effects of d-amphetamine, scopolamine, chlordiaze-poxide and diphenylhydantoin on self-stimulation behavior and brain acetylcholine. Psychopharmacologia 23:1–16PubMedGoogle Scholar
  283. 283.
    Olds ME (1976) Effectiveness of morphine and ineffectiveness of diazepam and phenobarbital on the motivational properties of hypothalamic self-stimulation behaviour. Neuropharmacology 15:117–131PubMedGoogle Scholar
  284. 284.
    Gomita Y, Ichimaru Y, Moriyama M, Araki H, Futagami K (2003) Effects of ­anxiolytic drugs on rewarding and aversive behaviors induced by intracranial stimulation. Acta Med Okayama 57:95–108PubMedGoogle Scholar
  285. 285.
    Liebman JM (1985) Anxiety, anxiolytics and brain stimulation reinforcement. Neurosci Biobehav Rev 9:75–86PubMedGoogle Scholar
  286. 286.
    Gomita Y, Ueki S (1981) “Conflict” situation based on intracranial self-stimulation behavior and the effect of benzodiazepines. Pharmacol Biochem Behav 14:219–222PubMedGoogle Scholar
  287. 287.
    Moriyama M, Ichimaru Y, Gomita Y (1984) Behavioral suppression using intracranial reward and punishment: effects of benzodiazepines. Pharmacol Biochem Behav 21:773–778PubMedGoogle Scholar
  288. 288.
    Ichimaru Y, Moriyama M, Gomita Y (1985) Auto-titration technique using intracranial self-stimulation and effects of antianxiety drugs. Jpn J Pharmacol 39:331–338PubMedGoogle Scholar
  289. 289.
    Carlezon WA Jr, Wise RA (1993) Phencyclidine-induced potentiation of brain stimulation reward: acute effects are not altered by repeated administration. Psychopharmacology (Berl) 111:402–408Google Scholar
  290. 290.
    Carlezon WA Jr, Wise RA (1996) Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology (Berl) 128:413–420Google Scholar
  291. 291.
    Carlezon WA Jr, Wise RA (1996) Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 16:3112–3122PubMedGoogle Scholar
  292. 292.
    Nichols DE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens: identification of a new therapeutic class: entactogens. J Psychoactive Drugs 18:305–313PubMedGoogle Scholar
  293. 293.
    Oberlender R, Nichols DE (1988) Drug discrimination studies with MDMA and amphetamine. Psychopharmacology (Berl) 95:71–76Google Scholar
  294. 294.
    Baylen CA, Rosenberg H (2006) A review of the acute subjective effects of MDMA/ecstasy. Addiction 101:933–947PubMedGoogle Scholar
  295. 295.
    Hubner CB, Bird M, Rassnick S, Kornetsky C (1988) The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward. Psychopharmacology (Berl) 95:49–51Google Scholar
  296. 296.
    Reid LD, Hubbell CL, Tsai J, Fishkin MD, Amendola CA (1996) Naltrindole, a δ-opioid antagonist, blocks MDMA’s ability to enhance pressing for rewarding brain stimulation. Pharmacol Biochem Behav 53:477–480PubMedGoogle Scholar
  297. 297.
    Bossert JM, Franklin KB (2003) Reinforcing versus anticonvulsant drugs: effects on intra-cranial self-stimulation rate-frequency M50 indices. Behav Brain Res 144:243–247PubMedGoogle Scholar
  298. 298.
    Semenova S, Markou A (2003) Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine. Biol Psychiatry 54:1249–1264PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Styliani Vlachou
    • 1
  • Athina Markou
    • 1
  1. 1.Department of Psychiatry, School of MedicineUniversity of California San DiegoLa Jolla, San DiegoUSA

Personalised recommendations